Home Notables Notable LGBTQ Executives Notable LGBTQ Executives: Dr. Alan Nyitray

Notable LGBTQ Executives: Dr. Alan Nyitray

Class of 2022

Alan Nyitray, associate professor at the Medical College of Wisconsin, transitioned from a role as director of HIV prevention services at an Arizona nonprofit to earn a doctorate degree in epidemiology. He has now become a leading authority in the prevention and early detection of HPV-associated cancers among men who have sex with men. 

Nyitray’s research is funded by the U.S. National Cancer Institute, and he is an author of more than 80 scientific articles in his field.

Nyitray is an internationally known epidemiologist and researcher pursuing cutting-edge projects to develop new tests and strategies to find cancers much earlier, said Krista Ruehmer, communications specialist at the Medical College.

“Much of his work is in anal cancer, which like cervical cancer is driven by human papillomavirus. However, in anal cancer there are currently no proven strategies for screening or early detection,” said Ruehmer. “Dr. Nyitray’s team is performing two studies to advance that science and move it quickly to the point where patients can immediately be helped.”

Alan Nyitray, associate professor at the Medical College of Wisconsin, transitioned from a role as director of HIV prevention services at an Arizona nonprofit to earn a doctorate degree in epidemiology. He has now become a leading authority in the prevention and early detection of HPV-associated cancers among men who have sex with men. 

Nyitray’s research is funded by the U.S. National Cancer Institute, and he is an author of more than 80 scientific articles in his field.

Nyitray is an internationally known epidemiologist and researcher pursuing cutting-edge projects to develop new tests and strategies to find cancers much earlier, said Krista Ruehmer, communications specialist at the Medical College.

“Much of his work is in anal cancer, which like cervical cancer is driven by human papillomavirus. However, in anal cancer there are currently no proven strategies for screening or early detection,” said Ruehmer. “Dr. Nyitray’s team is performing two studies to advance that science and move it quickly to the point where patients can immediately be helped.”

Stay up-to-date with our free email newsletter

Keep up with the issues, companies and people that matter most to business in the Milwaukee metro area.

By subscribing you agree to our privacy policy.

No, thank you.
Exit mobile version